Share:
Peer-Reviewed Publication
Haematologica2017;102(4):e144-e147.April 1, 2017Letter

Integration of B-cell receptor-induced ERK1/2 phosphorylation and mutations of SF3B1 gene refines prognosis in treatment-naïve chronic lymphocytic leukemia.

Chiara Cavallini1, Carlo Visco2, Santosh Putta3, Davide Rossi4, Elda Mimiola5, Norman Purvis6, Ornella Lovato1, Omar Perbellini2, Erika Falisi2, Monica Facco7, Livio Trentin7, Maria G Romanelli8, Gianpietro Semenzato7, Achille Ambrosetti5, Gianluca Gaidano9, Giovanni Pizzolo5, Alessandra Cesano10, Maria T Scupoli11,5
1Research Center LURM, University of Verona, Italy.
2Department of Cell Therapy and Hematology, San Bortolo Hospital, Vicenza, Italy.
3Qognit Inc., Foster City, CA, USA.
4Hematology, Oncology Institute of Southern Switzerland and Institute of Oncology Research, Bellinzona, Switzerland.
5Department of Medicine, Section of Hematology, University of Verona, Italy.
6Pierian Biosciences, Franklin, TN, USA.
7Department of Medicine, Hematology and Clinical Immunology Branch, University of Padua, Italy.
8Department of Neurosciences, Biomedicine and Movement Sciences, Section of Biology and Genetics, University of Verona, Italy.
9Department of Translational Medicine, Division of Hematology, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy.
10NanoString, Inc, Seattle, WA, USA.
11Research Center LURM, University of Verona, Italy mariateresa.scupoli@univr.it.

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.